CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smartphone ECG with AI could spot hidden heart disease in families
Diagnosis CompletedThis pilot study tested whether a portable 6-lead ECG device, paired with an artificial intelligence algorithm, can help screen first-degree relatives of people with dilated cardiomyopathy (a weakened heart muscle). The goal was to see if this mobile approach could detect reduced…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 23, 2026 20:48 UTC
-
Which MRI dye gives the best picture of heart damage?
Diagnosis CompletedThis study compared two contrast agents (Dotarem and Gadovist) used in cardiac MRI to see which provides clearer images of heart muscle damage. 120 adults with coronary artery disease or cardiomyopathy received one of the two dyes during their scan. Researchers rated image qualit…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Diagnosis
Last updated Jun 23, 2026 20:47 UTC
-
Heart drug fails to shield duchenne boys from cardiac decline
Prevention CompletedThis study tested whether nebivolol, a beta-blocker heart drug, could prevent heart failure in 51 boys aged 10-15 with Duchenne muscular dystrophy. Participants had normal heart function at the start and were randomly given either nebivolol or a placebo. The trial found that nebi…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 05, 2026 12:08 UTC
-
Heart failure mystery solved? Beta-Blockers' secret revealed
Knowledge-focused CompletedThis study looked at how beta-blocker medicines improve heart function in people with heart failure and a weakened heart muscle. Fifty-five adults with severe heart failure took part. Researchers measured changes in the heart's pumping ability to understand the underlying mechani…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Michael E. DeBakey VA Medical Center • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:50 UTC
-
Healthy volunteers test new heart Drug's absorption
Knowledge-focused CompletedThis study looked at how the body absorbs a new drug called HRS-1893, which is being developed for heart muscle disease (cardiomyopathy). 38 healthy adults took different versions of the tablet, with and without food, to see which form works best and if food changes how much drug…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Gene study seeks clues to inflammation and disease risk
Knowledge-focused CompletedThis study looked at how certain genes in blood cells respond to environmental exposures in 178 healthy volunteers aged 18 to 45. Researchers measured gene activity to better understand links to inflammation, cancer, and other diseases. The goal was to gather knowledge, not to pr…
Matched conditions: CARDIOMYOPATHY
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:07 UTC